ATN 076: Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
ID Number 00-0667-00031Principal Investigator(s)
John B Steever
Department(s) or Division(s)
This is a 'proof of concept' study that aims to evaluate supplemental material that could be used to enhance the informed consent procedures employed during recruitment for an HIV vaccine clinical trial. The goal of the supplemental material is to reduce the possibility that sexual disinhibition would occur in the context of the clinical trial. The material is designed to address two key concepts: randomization to vaccine and placebo groups, and the unknown efficacy of the experimental vaccine.
The primary mission of the Adolescent Medicine Trials Network (ATN) for HIV/AIDS Intervention is to conduct research, both independently and in collaboration with existing research networks such as the HIV Prevention Trials Network (HPTN), HIV Vaccine Trials Network (HVTN), and the Pediatric and Adult AIDS Clinical Trials Groups (PACTG, AACTG), the Community Programs for Clinical Research on AIDS (CPCRA), and others, on promising behavioral, microbicidal, prophylactic, therapeutic, and vaccine modalities in HIV-infected and HIV-at-risk adolescents, ages 12 through 24 years.
Recruiting Patients: Yes